Clinical Trial Update: WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture

View source ↗

Summary

Completed IMI PROTECT study WEUKBRE5559 assessing the relationship between benzodiazepine use and fracture risk in anxiety disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Benzodiazepines (class) (benzodiazepines)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anxiety Disorders | Status: COMPLETED